Het Algemeen Ziekenhuis Jan Portaels is een ziekenhuis in Vilvoorde. Het AZ Jan Portaels, genoemd naar 19e-eeuws schilder Jan Portaels, ontstond op 1 januari 2002 door een fusie van het Van Helmontziekenhuis van het OCMW en de Sint-Jozefkliniek van de CM Sint-Michielsbond.

During the past decade, AZ Jan Portaels conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Jan Portaels" #1 sponsor was "ID3 Medical" with 4 trials, followed by "Becton, Dickinson and Company" with 1 trials sponsored, "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 1 trials sponsored, "KU Leuven" with 1 trials sponsored and "P. Verschueren" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Jan Portaels" #1 collaborator was "Belgian Cancer Registry" with 1 trials as a collaborator, "Belgium Health Care Knowledge Centre" with 1 trials as a collaborator and "Ferring Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "AZ Jan Portaels" are "Peripheral Arterial Disease" (4 trials), "Prostate Cancer" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "AZ Jan Portaels" in a lesser frequency.

Most popular intervention types in "AZ Jan Portaels" are "Device" (4 trials), "Procedure" (3 trials), "Behavioral" (1 trials), "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BeGraft Peripheral Plus Stent Graft System" (1 trials), "Combination therapy DCB + stent" (1 trials), "Endarterectomy treatment group" (1 trials), "Etanercept 50 MG/ML" (1 trials) and "ICIQ questionnaire" (1 trials). Other intervention names were less common.

The vast majority of trials in "AZ Jan Portaels" are 6 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "AZ Jan Portaels". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in AZ Jan Portaels, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Jan Portaels, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".